AXGN Q3 2020 Earnings — AxoGen, Inc. Revenue & Financial Results | Market Cap Arena

AXGNAxoGen, Inc.

$2B

Q3 2020 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$33M+17.0% YoY

Gross Profit

$28M83.0% margin

Operating Income

-$1M-3.1% margin

Net Income

-$1M-4.4% margin

EPS (Diluted)

$-0.04

QoQ Revenue Growth

+51.1%

Cash Flow

Operating Cash Flow

$3M

Free Cash Flow

-$3M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$194M

Total Liabilities

$72M

Stockholders' Equity

$122M

Cash & Equivalents

$60M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$33M	$29M	+17.0%
Gross Profit	$28M	$24M	+15.3%
Operating Income	-$1M	-$6M	+82.9%
Net Income	-$1M	-$6M	+73.5%